Contact: Vanessa Solomon
Walter and Eliza Hall Institute
Caption: Dr Guillaume Lessene and his collaborators have tailor-made a new chemical compound that blocks a protein that has been linked to poor responses to treatment in cancer patients.
Credit: Walter and Eliza Hall Institute, Australia
Usage Restrictions: None
Related news release: Discovery brings hope of new tailor-made anti-cancer agents